13 resultados para Iljenkov, Evald
Resumo:
Kirjallisuusarvostelu
Resumo:
Myös esittely Iljenkovin elämästä ja tuotannosta.
Resumo:
kuv., 21 x 28 cm
Resumo:
kuv., 21 x 28 cm
Resumo:
Kustavilainen talonpoikaislaivuri Simon Jansson ja hänen vaimonsa Wilhelmina o.s. Widbom kävivät kolmenkymmenen vuoden ajan kirjeenvaihtoa kouluun ja yliopistoon lähetettyjen poikiensa Waldemar, Evald ja Emil Jahnssonin kanssa. Lähes 150 suomen- ja ruotsinkielistä kirjettä on säilynyt Suomalaisen Kirjallisuuden Seuran kirjallisuusarkistossa ja Turun maakunta-arkistossa. Lähiluvun kautta kirjeistä muodostuu yksityiskohtainen lähde saaristolaisperheen elämäntapaan, arkeen ja työhön sekä saaristoyhteisön sosiaalisen kanssakäymisen muotoihin. Ne kertovat myös ensimmäisen polven oppisivistyneistön synnystä ja niistä resursseista, joita hyödyntäen koulua käymättömät vanhemmat saattoivat kouluttaa lapsensa. Tutkimus liittyy suomalaisten 1800-luvun itseoppineiden kirjoittajien tekstien ja maaseudun kirjallistumisen tutkimukseen. Keskeinen käsite on egodokumentti, jolla tarkoitetaan kirjeitä ja muita tekstejä, joissa kirjoittaja kertoo itse omasta elämästään. Hollantilainen ja ranskalainen egodokumenttien tutkimus on pyrkinyt haastamaan uudenlaisten lähdeaineistojen kautta käsityksiä menneisyydestä sekä nostamaan esiin muun muassa yksilöllisen kokemuksen, kirjoittamisen kulttuurin ja dokumenttien materiaalisuuden. Janssonin perheen kirjeet poikkeavat monin tavoin 1800-luvun säätyläisten kirjeistä. Niiden funktio oli hyvin käytännöllinen ja arkinen, mutta ne olivat myös vanhempien keino tukea perheen yhteistä sosiaalisen nousun projektia. Kustavia koskevan tiheän uutisoinnin kautta ne pyrkivät pitämään kaupunkilaistuvat pojat osana vanhaa yhteisöään. Perheen isä vastasi suurelta osin kirjeenvaihdosta ja siihen liittyvästä huolenpidosta, mikä kertoo sukupuolittuneen työnjaon joustavuudesta saaristossa. Tutkimus osoittaa, ettei isän ammattiin perustuva yliopisto-opiskelijoiden tutkimus ole tavoittanut sitä naisten kautta välittyvää sosiaalista ja kulttuurista pääomaa, joka saattoi olla ratkaiseva perheiden kouluttaessa lapsiaan. Kirjeiden analyysi tarkentaa kuvaa perinteisen talonpoikaispurjehduksen sopeutumisesta vuosisadan loppupuolen uudistuksiin.
Resumo:
OBJECTIVES This study sought to describe the frequency and clinical impact of acute scaffold disruption and late strut discontinuity of the second-generation Absorb bioresorbable polymeric vascular scaffolds (Absorb BVS, Abbott Vascular, Santa Clara, California) in the ABSORB (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions) cohort B study by optical coherence tomography (OCT) post-procedure and at 6, 12, 24, and 36 months. BACKGROUND Fully bioresorbable scaffolds are a novel approach to treatment for coronary narrowing that provides transient vessel support with drug delivery capability without the long-term limitations of metallic drug-eluting stents. However, a potential drawback of the bioresorbable scaffold is the potential for disruption of the strut network when overexpanded. Conversely, the structural discontinuity of the polymeric struts at a late stage is a biologically programmed fate of the scaffold during the course of bioresorption. METHODS The ABSORB cohort B trial is a multicenter single-arm trial assessing the safety and performance of the Absorb BVS in the treatment of 101 patients with de novo native coronary artery lesions. The current analysis included 51 patients with 143 OCT pullbacks who underwent OCT at baseline and follow-up. The presence of acute disruption or late discontinuities was diagnosed by the presence on OCT of stacked, overhung struts or isolated intraluminal struts disconnected from the expected circularity of the device. RESULTS Of 51 patients with OCT imaging post-procedure, acute scaffold disruption was observed in 2 patients (3.9%), which could be related to overexpansion of the scaffold at the time of implantation. One patient had a target lesion revascularization that was presumably related to the disruption. Of 49 patients without acute disruption, late discontinuities were observed in 21 patients. There were no major adverse cardiac events associated with this finding except for 1 patient who had a non-ischemia-driven target lesion revascularization. CONCLUSIONS Acute scaffold disruption is a rare iatrogenic phenomenon that has been anecdotally associated with anginal symptoms, whereas late strut discontinuity is observed in approximately 40% of patients and could be viewed as a serendipitous OCT finding of a normal bioresorption process without clinical implications. (ABSORB Clinical Investigation, Cohort B [ABSORB B]; NCT00856856).
Resumo:
AIMS Patients with ST-segment elevation myocardial infarction (STEMI) feature thrombus-rich lesions with large necrotic core, which are usually associated with delayed arterial healing and impaired stent-related outcomes. The use of bioresorbable vascular scaffolds (Absorb) has the potential to overcome these limitations owing to restoration of native vessel lumen and physiology at long term. The purpose of this randomized trial was to compare the arterial healing response at short term, as a surrogate for safety and efficacy, between the Absorb and the metallic everolimus-eluting stent (EES) in patients with STEMI. METHODS AND RESULTS ABSORB-STEMI TROFI II was a multicentre, single-blind, non-inferiority, randomized controlled trial. Patients with STEMI who underwent primary percutaneous coronary intervention were randomly allocated 1:1 to treatment with the Absorb or EES. The primary endpoint was the 6-month optical frequency domain imaging healing score (HS) based on the presence of uncovered and/or malapposed stent struts and intraluminal filling defects. Main secondary endpoint included the device-oriented composite endpoint (DOCE) according to the Academic Research Consortium definition. Between 06 January 2014 and 21 September 2014, 191 patients (Absorb [n = 95] or EES [n = 96]; mean age 58.6 years old; 17.8% females) were enrolled at eight centres. At 6 months, HS was lower in the Absorb arm when compared with EES arm [1.74 (2.39) vs. 2.80 (4.44); difference (90% CI) -1.06 (-1.96, -0.16); Pnon-inferiority <0.001]. Device-oriented composite endpoint was also comparably low between groups (1.1% Absorb vs. 0% EES). One case of definite subacute stent thrombosis occurred in the Absorb arm (1.1% vs. 0% EES; P = ns). CONCLUSION Stenting of culprit lesions with Absorb in the setting of STEMI resulted in a nearly complete arterial healing which was comparable with that of metallic EES at 6 months. These findings provide the basis for further exploration in clinically oriented outcome trials.
Resumo:
AIMS The Absorb bioresorbable vascular scaffold (Absorb BVS) provides similar clinical outcomes compared with a durable polymer-based everolimus-eluting metallic stent (EES) in stable coronary artery disease patients. ST-elevation myocardial infarction (STEMI) lesions have been associated with delayed arterial healing and impaired stent-related outcomes. The purpose of the present study is to compare directly the arterial healing response, angiographic efficacy and clinical outcomes between the Absorb BVS and metallic EES. METHODS AND RESULTS A total of 191 patients with acute STEMI were randomly allocated to treatment with the Absorb BVS or a metallic EES 1:1. The primary endpoint is the neointimal healing (NIH) score, which is calculated based on a score taking into consideration the presence of uncovered and malapposed stent struts, intraluminal filling defects and excessive neointimal proliferation, as detected by optical frequency domain imaging (OFDI) six months after the index procedure. The study will provide 90% power to show non-inferiority of the Absorb BVS compared with the EES. CONCLUSIONS This will be the first randomised study investigating the arterial healing response following implantation of the Absorb BVS compared with the EES. The healing response assessed by a novel NIH score in conjunction with results on angiographic efficacy parameters and device-oriented events will elucidate disease-specific applications of bioresorbable scaffolds.
Resumo:
Collection primarily documents McCulloch's research on women's legal status, and her work with the Illinois Equal Suffrage Association, the National American Woman Suffrage Association, and the League of Women Voters. There is also documentation of women in the legal profession, of McCulloch's friendships with the other women suffragists and lawyers, and some biographical material. The papers contain little information about her family or social life.
Resumo:
Contains music.
Resumo:
Mode of access: Internet.